CYTOMED THERAPEUTICS
CytoMed Therapeutics is a cancer immunotherapy startup.
CYTOMED THERAPEUTICS
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.cytomed.sg
Total Employee:
1+
Status:
Active
Contact:
+65 9732 8844
Email Addresses:
[email protected]
Total Funding:
1.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Euro
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Investors List
SV Health Investors
SV Health Investors investment in Venture Round - CytoMed Therapeutics
mDR Group
mDR Group investment in Debt Financing - CytoMed Therapeutics
Official Site Inspections
http://www.cytomed.sg
- Host name: w127.mschosting.com
- IP address: 103.6.198.11
- Location: Malaysia
- Latitude: 1.55
- Longitude: 110.3333
- Timezone: Asia/Kuching
More informations about "CytoMed Therapeutics"
Cytomed - Advancing
CytoMed's Technologies. CytoMed is translating its patent-pending technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based "off-the-shelf" ... CytoMed Therapeutics is a …See details»
About - Cytomed
CytoMed Therapeutics. Incorporated in 2018, CytoMed Therapeutics is a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star) and focuses on …See details»
Our Mission - Cytomed
Our Mission . To produce effective, more affordable cellular immunotherapies for solid and blood-based cancers. Who We Are Incorporated in 2018, CytoMed is a biotech company spun off …See details»
CytoMed Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +65 9732 8844 CytoMed Therapeutics is a spin-off from Singapore's Agency for Science, Technology, and Research (A*Star) that …See details»
CytoMed Therapeutics
CytoMed Therapeutics. Incorporated in 2018, CytoMed Therapeutics is a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star) and focuses on …See details»
Cytomed Therapeutics - Investor Relations
Nov 12, 2024 Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s leading research and development agency …See details»
Cytomed Therapeutics - CytoMed Therapeutics Limited …
SINGAPORE, March 4, 2024 -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its …See details»
CYTOMED THERAPEUTICS LIMITED Company Profile | Singapore, …
Find company research, competitor information, contact details & financial data for CYTOMED THERAPEUTICS LIMITED of Singapore. Get the latest business insights from Dun & Bradstreet.See details»
Cytomed Therapeutics Ltd. Company Profile - Singapore - EMIS
Jul 9, 2024 CytoMed Therapeutics Limited is a biopharmaceutical company that develops novel cell-based immunotherapies for the treatment of various cancers. The Company is …See details»
Our Team - Cytomed
CytoMed team are passionate and experienced in translating our novel patient blood cell-independent platform technologies into “off-the-shelf” cell-based cancer immunotherapies to treat a broad-spectrum of cancers. ... He previously …See details»
Cytomed Therapeutics - Chinese Patent Granted for A*STAR …
Aug 1, 2023 The Company now has exclusive rights to a US and Chinese patent. SINGAPORE, Aug. 1, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" …See details»
CytoMed Therapeutics Company Profile 2024: Stock
CytoMed Therapeutics General Information Description. CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the …See details»
CytoMed Diversifies into Regenerative Medicine after Research ...
Mar 20, 2024 SINGAPORE / ACCESSWIRE / March 20, 2024 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company …See details»
CytoMed Therapeutics: Revolutionizing Cancer Treatment with …
Nov 12, 2024 Enter CytoMed Therapeutics Limited (NASDAQ: GDTC), a small-cap biotech company from Singapore that's revolutionizing cancer treatment through its groundbreaking …See details»
Manufacturer - Cytomed
[email protected]. Phone: +607-3824911 +65-62507738. Quick Links. Home; About Us; Publications; Contact Us; Let's Get Connected! CytoMed Therapeutics Limited (201808327H) …See details»
Cytomed Therapeutics - CytoMed Therapeutics completes cash …
SINGAPORE, October 3, 2024 - CytoMed Therapeutics Limited (NASDAQ: GDTC) (CytoMed or Company), a Singapore-based biopharmaceutical company focused on harnessing its …See details»
CytoMed Therapeutics completes cash acquisition of Cord Blood …
Oct 3, 2024 Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s leading research and development agency in the public sector. It is a ...See details»
About - staging.cytomed.sg
CytoMed Therapeutics. Incorporated in 2018, CytoMed Therapeutics is a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star) and focuses on …See details»
cytomed – Just another WordPress site
CytoMed's Technologies. CytoMed is translating its patent-pending technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based "off-the-shelf" ... CytoMed Therapeutics is a …See details»
Pipeline - Cytomed
[email protected]. Phone: +607-3824911 +65-62507738. Quick Links. Home; About Us; Publications; Contact Us; Let's Get Connected! CytoMed Therapeutics Limited (201808327H) …See details»